It's a fairly new drug, article is about it becoming available in Europe. I thought it was interesting though as how it works could be of benefit to us to I'd think at some point.
GSK, HGS lupus drug wins green light in Europe | Reuters
It's a fairly new drug, article is about it becoming available in Europe. I thought it was interesting though as how it works could be of benefit to us to I'd think at some point.
GSK, HGS lupus drug wins green light in Europe | Reuters
~ Bob
I couldn't help but notice how much of that article was spent discussing how profitable the drug would be for pharmaceutical companies. They barely even discussed what it does or how it will help people with Lupus.
In the articles defense it was in the business section I think ... But yeah...3.5 billion is mind boggling for a single drug. It's been available in the US for a bit now and there is a bit of information on it. Here's an article from the manufacturer website on how it works.
BENLYSTAŽ (belimumab)-HGS
~ Bob
Oh, LOL that makes sense. I actually looked to see if it was from a finance paper or something but I clearly missed the big STOCK QUOTES right under the article.
Hehe...well this might be the next RTX....price and what it does seems to be similar.
~ Bob
Bookmarks